TABLE 2.
Groups | Baseline mean (SD) | Day 30 mean (SD) | Day 60 mean (SD) | p‐values * (between baseline and day 60) | p‐value * (between‐group) |
---|---|---|---|---|---|
SOD (IU/mL) (range: 170–200 U/mL) | |||||
ARE | 151.99 (22.39) | 188.33 (15.60) | 192.18 (18.36) | <0.001 | <0.001 |
Placebo | 152.84 (20.58) | 131.28 (17.76) | 128.64 (18.88) | 0.027 | |
Catalase (IU/mL) | |||||
ARE | 307.91 (20.92) | 323.76 (19.29) | 330.22 (15.56) | <0.001 | <0.001 |
Placebo | 309.57 (15.59) | 287.49 (16.83) | 280.00 (16.56) | <0.001 | |
GSH (IU/mL) (range: 40–50 IU/mL) | |||||
ARE | 36.96 (2.99) | 48.44 (2.66) | 50.22 (3.85) | <0.001 | <0.001 |
Placebo | 36.29 (5.52) | 27.69 (3.67) | 26.27 (3.05) | <0.001 | |
Malondialdehyde (nM/mL) (range: 01–02 nM/mL) | |||||
ARE | 2.26 (0.22) | 1.29 (0.19) | 1.24 (0.19) | <0.001 | <0.001 |
Placebo | 2.20 (0.34) | 3.10 (0.44) | 3.15 (0.45) | <0.001 |
Abbreviations: ARE, ashwagandha root extract; GSH, glutathione; SOD, superoxide dismutase.
statistically significant. p < 0.05 is considered statistically significant.